TD Cowen Downgrades Hims & Hers Health (NYSE:HIMS) to Hold

Hims & Hers Health (NYSE:HIMS) was downgraded by stock analysts at TD Cowen from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday,Briefing.com Automated Import reports. They presently have a $30.00 price objective on the stock. TD Cowen’s price objective would indicate a potential upside of 5.23% from the company’s previous close.

Several other equities research analysts have also recently weighed in on HIMS. Morgan Stanley cut shares of Hims & Hers Health from an “overweight” rating to an “equal weight” rating and raised their price objective for the company from $42.00 to $60.00 in a research report on Tuesday, February 18th. Truist Financial cut their price target on shares of Hims & Hers Health from $39.00 to $33.00 and set a “hold” rating on the stock in a research report on Thursday, April 10th. Bank of America upped their target price on shares of Hims & Hers Health from $21.00 to $22.00 and gave the company an “underperform” rating in a report on Tuesday, March 18th. Piper Sandler increased their price target on shares of Hims & Hers Health from $24.00 to $35.00 and gave the company a “neutral” rating in a report on Tuesday, February 25th. Finally, Needham & Company LLC increased their price target on shares of Hims & Hers Health from $31.00 to $61.00 and gave the company a “buy” rating in a report on Tuesday, February 25th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, Hims & Hers Health presently has an average rating of “Hold” and a consensus target price of $38.25.

Hims & Hers Health Stock Up 1.5 %

Shares of HIMS stock opened at $28.51 on Tuesday. Hims & Hers Health has a fifty-two week low of $11.20 and a fifty-two week high of $72.98. The stock has a market capitalization of $6.33 billion, a P/E ratio of 64.80 and a beta of 1.65. The stock has a 50-day simple moving average of $33.44 and a 200 day simple moving average of $31.15.

Hims & Hers Health (NYSE:HIMS) last posted its earnings results on Monday, February 24th. The company reported $0.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.09 by $0.02. The firm had revenue of $481.14 million during the quarter, compared to analysts’ expectations of $494.56 million. Hims & Hers Health had a net margin of 8.19% and a return on equity of 10.97%. On average, sell-side analysts anticipate that Hims & Hers Health will post 0.29 earnings per share for the current year.

Insider Activity at Hims & Hers Health

In related news, CEO Andrew Dudum sold 100,000 shares of the stock in a transaction that occurred on Friday, January 31st. The shares were sold at an average price of $35.22, for a total transaction of $3,522,000.00. Following the transaction, the chief executive officer now owns 27,918 shares in the company, valued at $983,271.96. This represents a 78.18 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Irene Becklund sold 2,203 shares of the stock in a transaction that occurred on Thursday, April 3rd. The stock was sold at an average price of $28.78, for a total transaction of $63,402.34. Following the completion of the transaction, the insider now owns 8,007 shares in the company, valued at $230,441.46. The trade was a 21.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 712,998 shares of company stock worth $27,992,450 over the last 90 days. 17.71% of the stock is owned by company insiders.

Institutional Investors Weigh In On Hims & Hers Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Means Investment CO. Inc. lifted its position in shares of Hims & Hers Health by 23.5% in the 4th quarter. Means Investment CO. Inc. now owns 50,040 shares of the company’s stock worth $1,210,000 after purchasing an additional 9,508 shares during the period. Principal Financial Group Inc. lifted its position in shares of Hims & Hers Health by 102.0% during the 3rd quarter. Principal Financial Group Inc. now owns 290,414 shares of the company’s stock valued at $5,349,000 after buying an additional 146,621 shares in the last quarter. Raymond James Financial Inc. purchased a new position in Hims & Hers Health in the 4th quarter valued at $18,048,000. State of Alaska Department of Revenue purchased a new position in shares of Hims & Hers Health during the 4th quarter worth $2,628,000. Finally, Pacer Advisors Inc. acquired a new stake in shares of Hims & Hers Health during the 4th quarter worth about $374,000. 63.52% of the stock is currently owned by hedge funds and other institutional investors.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.